TE_171

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MSTC
TE superfamily MaLR
TE class LTR
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 1.99
Counts of samples TCGA_tumor:135; TCGA_normal:4; GTEx:72
TSS chr1(-):17140154



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_171.11 - Intergenic Non-coding Non-coding chr1(-):17134677,17134697,17134793,17136628,17140023,17140155
teRNA_171.12 - Intergenic Non-coding Non-coding chr1(-):17134623,17134643,17134773,17134935,17135105,17139185,17140023,17140155
teRNA_171.13 - Intergenic Non-coding Non-coding chr1(-):17134693,17134713,17134773,17136628,17138319,17139185,17140023,17140155
teRNA_171.14 - Intergenic Non-coding Non-coding chr1(-):17134737,17134757,17134846,17139185,17140023,17140155


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).